Authors:
Haq, IU
Ramsay, LE
Wallis, EJ
Isles, CG
Ritchie, LD
Jackson, PR
Citation: Iu. Haq et al., Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey, HEART, 86(3), 2001, pp. 289-295
Authors:
Sanmuganathan, PS
Ghahramani, P
Jackson, PR
Wallis, EJ
Ramsay, LE
Citation: Ps. Sanmuganathan et al., Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials, HEART, 85(3), 2001, pp. 265-271
Authors:
Wallis, EJ
Ramsay, LE
Haq, IU
Ghahramani, P
Jackson, PR
Citation: Ej. Wallis et al., Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation, J HYPERTENS, 19(4), 2001, pp. 691-696
Citation: Dj. Leach et al., Realizing the potential of empowerment: the impact of a feedback intervention on the performance of complex technology, ERGONOMICS, 44(9), 2001, pp. 870-886
Authors:
Ramsey, LE
Sanmuganathan, PS
Wallis, EJ
Jackson, PR
Citation: Le. Ramsey et al., Aspirin for primary prevention - Treatment policy should be based on all trial evidence, not subgroup analysis, BR MED J, 321(7274), 2000, pp. 1472-1472
Citation: Pr. Jackson et al., Optimal age for starting lipid lowering treatment - Adjusted data do not justify a lower optimal age, BR MED J, 321(7261), 2000, pp. 637-638
Authors:
Wallis, EJ
Ramsay, LE
Yikona, JINM
Jackson, PR
Citation: Ej. Wallis et al., Comparison of methods of estimating coronary risk - Authors did not use latest version of Sheffield table, BR MED J, 321(7254), 2000, pp. 175-176
Authors:
Wallis, EJ
Ramsay, LE
Haq, IU
Ghahramani, P
Jackson, PR
Rowland-Yeo, K
Yeo, WW
Citation: Ej. Wallis et al., Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population, BR MED J, 320(7236), 2000, pp. 671-676
Citation: Pr. Jackson et Le. Ramsay, Debate: at what level of coronary heart disease risk should a statin be prescribed?, CURR OP LIP, 11(4), 2000, pp. 357-361
Citation: Ca. Sprigg et al., Production teamworking: The importance of interdependence and autonomy foremployee strain and satisfaction, HUMAN RELAT, 53(11), 2000, pp. 1519-1543
Authors:
Haq, IU
Ramsay, LE
Jackson, PR
Wallis, EJ
Citation: Iu. Haq et al., Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods, QJM-MON J A, 92(7), 1999, pp. 379-385
Authors:
Pickin, DM
McCabe, CJ
Ramsay, LE
Payne, N
Haq, IU
Yeo, WW
Jackson, PR
Citation: Dm. Pickin et al., Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment, HEART, 82(3), 1999, pp. 325-332
Authors:
Haq, IU
Ramsay, LE
Yeo, WW
Jackson, PR
Wallis, EJ
Citation: Iu. Haq et al., Is the Framingham risk function valid for northern European populations? Acomparison of methods for estimating absolute coronary risk in high risk men, HEART, 81(1), 1999, pp. 40-46
Citation: P. Ghahramani et al., Fraction of dose of drug converted to a metabolite when both compete for metabolism by the same enzyme, BR J CL PH, 47(5), 1999, pp. 578-578
Authors:
Haq, IU
Minnis, R
Wallis, EJ
Palmer, R
Yeo, WW
Jackson, PR
Ramsay, LE
Citation: Iu. Haq et al., Randomized trial of step-3 diet vs simvastatin therapy for reduction in risk of coronary heart disease, BR J CL PH, 47(5), 1999, pp. 597-598
Authors:
Rowland, K
Yeo, WW
Jackson, PR
Ramsay, LE
Citation: K. Rowland et al., Effect of diltiazem on the cholesterol-lowering response to simvastatin: aCYP3A4-mediated reaction, BR J CL PH, 47(5), 1999, pp. 598-598